Skip to content

Growth and Nutritional Impact of Small Fish Powder Supplementation in Infants

Assessing the Efficacy of Small Fish Powder Supplementation on the Growth of Infants Aged 6-7 Months in Northern Cameroon

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07794085
Enrollment
240
Registered
2026-08-31
Start date
2024-07-01
Completion date
2025-02-01
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child Malnutrition

Keywords

Small fish powder, Complementary feeding, Infant malnutrition, Nutritional effectiveness, Northern Cameroon

Brief summary

This randomized controlled trial evaluated the effectiveness of supplementing the diets of infants aged 6-7 months with small fish powder on growth outcomes in the Garoua 1st Health District, Northern Cameroon. A total of 240 infants were enrolled and randomly assigned to receive either small fish powder or a millet flour control for six months. The primary endpoint was growth effectiveness, defined as achieving a height-for-age Z-score ≥ -1.5 after six months. Secondary outcomes included prevention of acute malnutrition, weight gain, mid-upper arm circumference (MUAC) gain, morbidity frequency, and intervention failure rate. Study procedures comprised weekly ration distribution, anthropometric measurements, hemoglobin and malaria testing, and parental nutritional education. Data were analyzed using SPSS and XLSTAT, with statistical significance set at p \< 0.05.

Interventions

DIETARY_SUPPLEMENTSmall Fish Powder

Infants aged 6-7 months will receive a daily ration of small fish powder equivalent to \~25 kcal/day, providing approximately 65% of the recommended daily protein intake for children aged 6-24 months. Parents will be instructed on how to incorporate the powder into the child's usual diet. Weekly distribution will occur at the health center, accompanied by monthly nutrition education and biweekly clinical monitoring.

DIETARY_SUPPLEMENTMillet Flour

Infants aged 6-7 months will receive a daily ration of millet flour equivalent to \~25 kcal/day, providing approximately 10% of the recommended daily protein intake for children aged 6-24 months. To standardize taste, 3% fish powder will be added. Parents will be instructed on how to incorporate the flour into the child's usual diet. Weekly distribution will occur at the health center, accompanied by monthly nutrition education and biweekly clinical monitoring.

Sponsors

Centre for Food and Nutrition Research, Yaounde
Lead SponsorOTHER_GOV
Ministry of Public Health, Cameroon
CollaboratorUNKNOWN
UNICEF
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Intervention model description

This study is a comparative effectiveness trial evaluating infant growth from 6-7 months of age over a six month period. A randomized controlled parallel design will be used, with allocation to either small fish powder supplementation or a control prepared with millet flour. A randomization list will be generated using a random number generator (Stat Trek). Allocation will be determined by parents drawing coded numbers from an opaque bag, each corresponding to one of the products. The code will be accessible only to distribution staff. Clinical evaluators will remain blinded to group assignment. If two infants belong to the same household, they will receive the same product to minimize potential confusion.

Eligibility

Sex/Gender
ALL
Age
6 Months to 7 Months
Healthy volunteers
Yes

Inclusion criteria

* Infants aged 6-7 months. * Families residing in the study area with no plans to relocate during the study period. * Absence of severe illness at enrollment.

Exclusion criteria

* Severe anemia. * Severe acute malnutrition. * Clinically defined illness such as dehydration, severe diarrhea, or respiratory disease.

Design outcomes

Primary

MeasureTime frameDescription
Height-for-Age Z-score6 monthsGrowth effectiveness, defined as the proportion of children achieving a height-for-age Z-score ≥ -1.5 SD after six months of supplementation.

Secondary

MeasureTime frameDescription
Weight-for-Height Z-score6 monthsPrevention of acute malnutrition, defined as weight-for-height Z-score ≥ -1.5 SD.
Weight Gain6 monthsMean change in body weight (kg) from baseline to six months.
Mid-Upper Arm Circumference (MUAC) Gain6 monthsMean change in MUAC (cm) from baseline to six months.
Morbidity Frequency6 monthsNumber of morbidity episodes (e.g., diarrhea, respiratory infections, malaria) recorded per child during the six-month intervention period.
Intervention Failure Rate6 monthsProportion of children failing to achieve growth effectiveness (height-for-age Z-score \< -1.5 SD) after six months.

Countries

Cameroon

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 1, 2026